Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3

Author:  ["Shie-Pon Tzung","Kristine M. Kim","Gorka Basañez","Chris D. Giedt","Julian Simon","Joshua Zimmerberg","Kam Y. J. Zhang","David M. Hockenbery"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

The Bcl-2-related survival proteins confer cellular resistance to a wide range of agents. Bcl-xL-expressing hepatocyte cell lines are resistant to tumour necrosis factor and anti-cancer drugs, but are more sensitive than isogenic control cells to antimycin A, an inhibitor of mitochondrial electron transfer. Computational molecular docking analysis predicted that antimycin A interacts with the Bcl-2 homology domain 3 (BH3)-binding hydrophobic groove of Bcl-xL. We demonstrate that antimycin A and a Bak BH3 peptide bind competitively to recombinant Bcl-2. Antimycin A and BH3 peptide both induce mitochondrial swelling and loss of ΔΨm on addition to mitochondria expressing Bcl-xL. The 2-methoxy derivative of antimycin A3 is inactive as an inhibitor of cellular respiration but still retains toxicity for Bcl-xL+ cells and mitochondria. Finally, antimycin A inhibits the pore-forming activity of Bcl-xL in synthetic liposomes, demonstrating that a small non-peptide ligand can directly inhibit the function of Bcl-2-related proteins.

Cite this article

Tzung, SP., Kim, K., Basañez, G. et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat Cell Biol 3, 183–191 (2001). https://doi.org/10.1038/35055095

View full text

>> Full Text:   Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress